-
Fund Dashboard
- Holdings
abrdn Healthcare Investors
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
AMGN Amgen Inc. | 75.36 mm | 233.87 k shares | 7.11 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 72.21 mm | 68.69 k shares | 6.82 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 67.25 mm | 802.11 k shares | 6.35 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 56.81 mm | 122.16 k shares | 5.36 | Common equity | Long | USA |
AstraZeneca PLC
|
37.32 mm | 479.07 k shares | 3.52 | Common equity | Long | UK |
BIIB Biogen Inc. | 36.39 mm | 187.73 k shares | 3.44 | Common equity | Long | USA |
State Street Institutional US Government Money Market Fund | 34.43 mm | 34.43 mm shares | 3.25 | Short-term investment vehicle | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 27.38 mm | 99.55 k shares | 2.58 | Common equity | Long | USA |
LLY Eli Lilly and Company | 25.36 mm | 28.63 k shares | 2.39 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 24.73 mm | 198.03 k shares | 2.33 | Common equity | Long | USA |
ILMN Illumina, Inc. | 22.87 mm | 175.35 k shares | 2.16 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 20.53 mm | 292.10 k shares | 1.94 | Common equity | Long | USA |
ABBV AbbVie Inc. | 17.98 mm | 91.04 k shares | 1.70 | Common equity | Long | USA |
UNH UnitedHealth Group Incorporated | 17.84 mm | 30.51 k shares | 1.68 | Common equity | Long | USA |
ARGX argenx SE | 17.61 mm | 32.49 k shares | 1.66 | Common equity | Long | Netherlands |
NEUROVANCE MILESTONE INTEREST
|
16.75 mm | 49.01 k shares | 1.58 | Common equity | Long | USA |
TMO Thermo Fisher Scientific Inc. | 16.70 mm | 26.99 k shares | 1.58 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 16.32 mm | 745.35 k shares | 1.54 | Common equity | Long | USA |
ASND Ascendis Pharma A/S | 15.87 mm | 106.30 k shares | 1.50 | Common equity | Long | Denmark |
ISRG Intuitive Surgical, Inc. | 15.85 mm | 32.27 k shares | 1.50 | Common equity | Long | USA |
BNTX BioNTech SE | 15.67 mm | 131.91 k shares | 1.48 | Common equity | Long | Germany |
JNJ Johnson & Johnson | 13.47 mm | 83.10 k shares | 1.27 | Common equity | Long | USA |
MRK Merck & Co., Inc. | 12.83 mm | 113.02 k shares | 1.21 | Common equity | Long | USA |
ABT Abbott Laboratories | 12.70 mm | 111.42 k shares | 1.20 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 11.66 mm | 159.30 k shares | 1.10 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 10.28 mm | 89.23 k shares | 0.97 | Common equity | Long | USA |
CURASEN THERAPEUTICS, INC. | 10.12 mm | 21.11 mm shares | 0.96 | Preferred equity | Long | USA |
INSP Inspire Medical Systems, Inc. | 9.60 mm | 45.50 k shares | 0.91 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 9.50 mm | 171.10 k shares | 0.90 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 9.49 mm | 179.73 k shares | 0.90 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 9.06 mm | 317.95 k shares | 0.86 | Common equity | Long | USA |
ELV Elevance Health Inc. | 8.23 mm | 15.83 k shares | 0.78 | Common equity | Long | USA |
BDX Becton, Dickinson and Company | 7.96 mm | 33.00 k shares | 0.75 | Common equity | Long | USA |
MEDP Medpace Holdings, Inc. | 7.38 mm | 22.11 k shares | 0.70 | Common equity | Long | USA |
BSX Boston Scientific Corporation | 6.88 mm | 82.06 k shares | 0.65 | Common equity | Long | USA |
Alkermes PLC
|
6.87 mm | 245.59 k shares | 0.65 | Common equity | Long | Ireland |
DHR Danaher Corporation | 6.61 mm | 23.78 k shares | 0.62 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 6.52 mm | 162.85 k shares | 0.62 | Common equity | Long | USA |
GPCR Structure Therapeutics Inc. | 6.46 mm | 147.09 k shares | 0.61 | Common equity | Long | Cayman Islands |
PFE Pfizer Inc. | 6.41 mm | 221.44 k shares | 0.61 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 6.29 mm | 215.88 k shares | 0.59 | Common equity | Long | USA |
HCA HCA Healthcare, Inc. | 6.18 mm | 15.20 k shares | 0.58 | Common equity | Long | USA |
HOTSPOT THERAPEUTICS, INC. | 5.95 mm | 2.88 mm shares | 0.56 | Preferred equity | Long | USA |
MRNA Moderna, Inc. | 5.94 mm | 88.94 k shares | 0.56 | Common equity | Long | USA |
ZTS Zoetis Inc. | 5.81 mm | 29.73 k shares | 0.55 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 5.74 mm | 50.20 k shares | 0.54 | Common equity | Long | USA |
XENE Xenon Pharmaceuticals Inc. | 5.42 mm | 137.70 k shares | 0.51 | Common equity | Long | Canada |
GH Guardant Health, Inc. | 5.34 mm | 232.79 k shares | 0.50 | Common equity | Long | USA |
Teva Pharmaceutical Industries Ltd
|
5.26 mm | 291.67 k shares | 0.50 | Common equity | Long | Israel |
KRYS Krystal Biotech, Inc. | 5.23 mm | 28.73 k shares | 0.49 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 5.23 mm | 201.46 k shares | 0.49 | Common equity | Long | USA |
MOH Molina Healthcare, Inc. | 5.17 mm | 14.99 k shares | 0.49 | Common equity | Long | USA |
uniQure NV
|
5.12 mm | 1.04 mm shares | 0.48 | Common equity | Long | Netherlands |
ENGRAIL THERAPEUTICS INC. SERI | 5.05 mm | 4.77 mm shares | 0.48 | Preferred equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 4.96 mm | 156.63 k shares | 0.47 | Common equity | Long | USA |
BMY Bristol-Myers Squibb Company | 4.93 mm | 95.36 k shares | 0.47 | Common equity | Long | USA |
THC Tenet Healthcare Corporation | 4.78 mm | 28.77 k shares | 0.45 | Common equity | Long | USA |
Medtronic PLC
|
4.72 mm | 52.38 k shares | 0.45 | Common equity | Long | Ireland |
APLS Apellis Pharmaceuticals, Inc. | 4.50 mm | 156.04 k shares | 0.42 | Common equity | Long | USA |
AMLX Amylyx Pharmaceuticals, Inc. | 4.43 mm | 1.37 mm shares | 0.42 | Common equity | Long | USA |
ENDEAVOR BIOMEDICINES, INC. | 4.29 mm | 657.32 k shares | 0.40 | Preferred equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 4.18 mm | 215.59 k shares | 0.39 | Common equity | Long | USA |
INSM Insmed Incorporated | 3.99 mm | 54.61 k shares | 0.38 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 3.91 mm | 74.68 k shares | 0.37 | Common equity | Long | USA |
EWTX Edgewise Therapeutics, Inc. | 3.74 mm | 139.95 k shares | 0.35 | Common equity | Long | USA |
IDXX IDEXX Laboratories, Inc. | 3.60 mm | 7.13 k shares | 0.34 | Common equity | Long | USA |
GERN Geron Corporation | 3.55 mm | 781.46 k shares | 0.33 | Common equity | Long | USA |
QLARIS BIO, INC. | 3.45 mm | 4.39 mm shares | 0.33 | Preferred equity | Long | USA |
ARBOR BIOTECHNOLOGIES | 3.40 mm | 827.25 k shares | 0.32 | Preferred equity | Long | USA |
Incendia Therapeutics, Inc. | 3.40 mm | 1.77 mm shares | 0.32 | Preferred equity | Long | USA |
MCK McKesson Corporation | 3.38 mm | 6.84 k shares | 0.32 | Common equity | Long | USA |
Oculis Holding AG
|
3.36 mm | 274.23 k shares | 0.32 | Common equity | Long | Switzerland |
ADPT Adaptive Biotechnologies Corporation | 3.32 mm | 647.79 k shares | 0.31 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 3.31 mm | 413.50 k shares | 0.31 | Common equity | Long | USA |
DXCM DexCom, Inc. | 3.27 mm | 48.71 k shares | 0.31 | Common equity | Long | USA |
PODD Insulet Corporation | 3.25 mm | 13.97 k shares | 0.31 | Common equity | Long | USA |
QUELL THERAPEUTICS | 3.23 mm | 1.55 mm shares | 0.30 | Preferred equity | Long | USA |
INVETX MILESTONE INTEREST | 3.12 mm | 31.19 k shares | 0.29 | Preferred equity | Long | USA |
RECODE THERAPEUTICS | 3.06 mm | 331.41 k shares | 0.29 | Preferred equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 2.99 mm | 321.39 k shares | 0.28 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 2.99 mm | 29.20 k shares | 0.28 | Common equity | Long | USA |
TNDM Tandem Diabetes Care, Inc. | 2.94 mm | 69.29 k shares | 0.28 | Common equity | Long | USA |
ABCURO, INC. | 2.93 mm | 532.82 k shares | 0.28 | Preferred equity | Long | USA |
SEISMIC THERAPEUTICS, INC. | 2.92 mm | 647.72 k shares | 0.28 | Preferred equity | Long | USA |
AVTR Avantor, Inc. | 2.84 mm | 109.66 k shares | 0.27 | Common equity | Long | USA |
Merus NV
|
2.81 mm | 56.17 k shares | 0.26 | Common equity | Long | Netherlands |
EW Edwards Lifesciences Corporation | 2.73 mm | 41.37 k shares | 0.26 | Common equity | Long | USA |
MRNS Marinus Pharmaceuticals, Inc. | 2.70 mm | 1.53 mm shares | 0.25 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 2.67 mm | 31.92 k shares | 0.25 | Common equity | Long | USA |
PYXS Pyxis Oncology, Inc. | 2.30 mm | 626.64 k shares | 0.22 | Common equity | Long | USA |
SYK Stryker Corporation | 2.16 mm | 5.97 k shares | 0.20 | Common equity | Long | USA |
GRAL GRAIL, Inc. | 2.01 mm | 145.94 k shares | 0.19 | Common equity | Long | USA |
MDGL Madrigal Pharmaceuticals, Inc. | 1.95 mm | 263.89 k shares | 0.18 | Common equity | Long | USA |
THIRD ARC BIO, INC | 1.95 mm | 926.72 k shares | 0.18 | Preferred equity | Long | USA |
HOTSPOT THERAPEUTICS, INC. | 1.84 mm | 632.39 k shares | 0.17 | Preferred equity | Long | USA |
AMOLYT MILESTONE | 1.69 mm | 15.98 k shares | 0.16 | Preferred equity | Long | USA |
Dynacure SA | 1.66 mm | 243.46 k shares | 0.16 | Preferred equity | Long | France |
AKRO Akero Therapeutics, Inc. | 1.64 mm | 57.18 k shares | 0.15 | Common equity | Long | USA |
XNCR Xencor, Inc. | 1.57 mm | 78.14 k shares | 0.15 | Common equity | Long | USA |
INCENDIA THERAPEUTICS, INC. | 1.57 mm | 1.57 mm principal | 0.15 | Debt | Long | USA |
GLYCOMINE, INC. | 1.56 mm | 2.60 mm shares | 0.15 | Preferred equity | Long | USA |
ARBOR BIOTECHNOLOGIES | 1.36 mm | 82.08 k shares | 0.13 | Preferred equity | Long | USA |
ARKUDA THERAPEUTICS, INC. | 1.20 mm | 1.04 mm shares | 0.11 | Preferred equity | Long | USA |
NTRA Natera, Inc. | 1.19 mm | 9.37 k shares | 0.11 | Common equity | Long | USA |
OCULIS HOLDING AG
|
963.29 k | 78.54 k shares | 0.09 | Common equity | Long | USA |
RLYB Rallybio Corporation | 883.44 k | 755.08 k shares | 0.08 | Common equity | Long | USA |
ZBIO Zenas BioPharma, Inc. | 872.89 k | 51.59 k shares | 0.08 | Common equity | Long | USA |
HIBERCELL, INC. SERIES B | 850.90 k | 2.77 mm shares | 0.08 | Preferred equity | Long | USA |
CURASEN THERAPEUTICS, INC. | 798.27 k | 1.66 mm shares | 0.08 | Preferred equity | Long | USA |
ENDEAVOR BIOMEDICINES INC. | 791.94 k | 121.38 k shares | 0.07 | Preferred equity | Long | USA |
BIOTHERYX, INC. SERIES E | 736.21 k | 1.30 mm shares | 0.07 | Preferred equity | Long | USA |
HOTSPOT THERAPEUTICS, INC. | 720.87 k | 720.87 k principal | 0.07 | Debt | Long | USA |
HIBERCELL,INC. SERIES C | 708.97 k | 1.53 mm shares | 0.07 | Preferred equity | Long | USA |
TCRX TScan Therapeutics, Inc. | 687.52 k | 138.06 k shares | 0.06 | Common equity | Long | USA |
NVAX Novavax, Inc. | 469.68 k | 37.19 k shares | 0.04 | Common equity | Long | USA |
HIBERCELL, INC. | 439.00 k | 439.00 k principal | 0.04 | Debt | Long | USA |
STRO Sutro Biopharma, Inc. | 240.09 k | 69.39 k shares | 0.02 | Common equity | Long | USA |
CONTRA CHINOOK THERAPE | 207.47 k | 91.80 k shares | 0.02 | Equity derivative | N/A | USA |
PRAX Praxis Precision Medicines, Inc. | 197.19 k | 3.43 k shares | 0.02 | Common equity | Long | USA |
IMAB I-Mab | 66.82 k | 53.89 k shares | 0.01 | Common equity | Long | Cayman Islands |
Mural Oncology PLC
|
54.43 k | 17.39 k shares | 0.01 | Common equity | Long | Ireland |
GRTX Galera Therapeutics, Inc. | 21.35 k | 296.46 k shares | 0.00 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 20.67 k | 230.00 shares | 0.00 | Common equity | Long | USA |
CONTRA FUSION PHARMACE | 10.48 k | 7.59 k shares | 0.00 | Equity derivative | N/A | Canada |
TETRAPHASE PHARMACEUTICALS INC | 1.72 k | 28.75 k shares | 0.00 | Equity derivative | N/A | USA |
ARKUDA THERAPEUTICS,INC SER A. | 235.39 | 2.35 mm shares | 0.00 | Preferred equity | Long | USA |
IO LIGHT HOLDINIGS, INC. | 42.16 | 421.63 k shares | 0.00 | Preferred equity | Long | USA |
PRIOTHERA LIMITED | 38.59 | 346.67 k shares | 0.00 | Preferred equity | Long | Ireland |
Willow Laboratories Inc.
|
16.00 | 160.00 k shares | 0.00 | Common equity | Long | USA |
HIBERCELL INC. | 5.49 | 5.49 mm shares | 0.00 | Equity derivative | N/A | USA |
HIBERCELL, INC. SERIES C | 1.53 | 1.53 mm shares | 0.00 | Equity derivative | N/A | USA |
CONTRA SPECTRUM PHARMA | 0.08 | 79.79 k shares | 0.00 | Equity derivative | N/A | USA |
AFFERENT MILESTONE INTEREST
|
0.03 | 26.21 k shares | 0.00 | Common equity | Long | USA |
ETHISMOS RESEARCH, INC. MILEST | 0 | 1.18 k shares | 0.00 | Preferred equity | Long | USA |
AMPHIVENA MILESTONE INTEREST | 0 | 100.00 shares | 0.00 | Preferred equity | Long | USA |
MODERNA INC | -143.00 | -143.00 contracts | -0.00 | Equity derivative | N/A | USA |
REGENERON PHARMACEUTICALS INC | -1.13 k | -9.00 contracts | -0.00 | Equity derivative | N/A | USA |
MCKESSON CORP | -1.25 k | -20.00 contracts | -0.00 | Equity derivative | N/A | USA |
VERTEX PHARMACEUTICALS INC | -1.58 k | -21.00 contracts | -0.00 | Equity derivative | N/A | USA |
AMGEN INC | -1.62 k | -30.00 contracts | -0.00 | Equity derivative | N/A | USA |
PFIZER INC | -1.71 k | -342.00 contracts | -0.00 | Equity derivative | N/A | USA |
BOSTON SCIENTIFIC CORP | -2.72 k | -121.00 contracts | -0.00 | Equity derivative | N/A | USA |
IDEXX LABORATORIES INC | -3.42 k | -19.00 contracts | -0.00 | Equity derivative | N/A | USA |
JOHNSON + JOHNSON | -3.53 k | -62.00 contracts | -0.00 | Equity derivative | N/A | USA |
AVANTOR INC | -3.89 k | -389.00 contracts | -0.00 | Equity derivative | N/A | USA |
ABBOTT LABORATORIES | -5.28 k | -88.00 contracts | -0.00 | Equity derivative | N/A | USA |
INTRA-CELLULAR THERAPIES INC | -5.36 k | -134.00 contracts | -0.00 | Equity derivative | N/A | USA |
MOLINA HEALTHCARE INC | -5.58 k | -29.00 contracts | -0.00 | Equity derivative | N/A | USA |
DEXCOM INC | -5.68 k | -142.00 contracts | -0.00 | Equity derivative | N/A | USA |
TANDEM DIABETES CARE INC | -5.99 k | -214.00 contracts | -0.00 | Equity derivative | N/A | USA |
CYTOKINETICS INC | -6.19 k | -165.00 contracts | -0.00 | Equity derivative | N/A | USA |
TENET HEALTHCARE CORP | -7.69 k | -61.00 contracts | -0.00 | Equity derivative | N/A | USA |
ALKERMES PLC | -9.82 k | -357.00 contracts | -0.00 | Equity derivative | N/A | Ireland |
ELI LILLY + CO | -9.86 k | -17.00 contracts | -0.00 | Equity derivative | N/A | USA |
INSULET CORP | -10.46 k | -41.00 contracts | -0.00 | Equity derivative | N/A | USA |
TEVA PHARMACEUTICAL INDUSTRIES | -11.18 k | -559.00 contracts | -0.00 | Equity derivative | N/A | Israel |
ABBVIE INC | -11.45 k | -53.00 contracts | -0.00 | Equity derivative | N/A | USA |
THERMO FISHER SCIENTIFIC INC | -11.56 k | -17.00 contracts | -0.00 | Equity derivative | N/A | USA |
ALNYLAM PHARMACEUTICALS INC | -14.25 k | -37.00 contracts | -0.00 | Equity derivative | N/A | USA |
INSPIRE MEDICAL SYSTEMS INC | -18.33 k | -47.00 contracts | -0.00 | Equity derivative | N/A | USA |
INTUITIVE SURGICAL INC | -18.90 k | -21.00 contracts | -0.00 | Equity derivative | N/A | USA |
ULTRAGENYX PHARMACEUTICAL INC | -18.98 k | -165.00 contracts | -0.00 | Equity derivative | N/A | USA |
ZOETIS INC | -22.00 k | -55.00 contracts | -0.00 | Equity derivative | N/A | USA |
ASCENDIS PHARMA A/S | -48.15 k | -107.00 contracts | -0.00 | Equity derivative | N/A | Denmark |